A new report from Cambridge Consultants declares that a broken reimbursement system is stifling innovation in minimally invasive surgery (MIS). The firm evaluated barriers and opportunities for future growth in the $15 billion MIS market during a recent summit in Boston with experts in imaging and navigation, regulatory affairs, surgical robotics, endoscopy, and laparoscopy. According the report, the current coding system rewards quick and profitable devices and procedures, with efficacy and patient care playing second fiddle.

June 2, 2010

1 Min Read
MIS: Reimbursement in the Way of Innovation

And despite the need to develop new treatment methods to combat infection and speed up recovery time in patients, the current system facilitates the status quo.

“The existing reimbursement coding system is stifling true leapfrog innovation,” said Andrew Diston, Head of Global Medical Technology Practice, Cambridge Consultants. “Even in today’s challenging economy, it is the long-term, sometimes higher-capital investments that will in the end bring about the improvements that can radically reduce MIS costs and improve patient outcomes in the process. Device makers want codes that reward innovation and patient care rather than short, dispensable income. This reimbursement issue has been hidden under the layers as an afterthought for too long.”

Request a full copy of the report, called "Navigating Surgical Options: The Future of Minimally Invasive Surgery," here.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like